CLBS
Caladrius Biosciences Inc
Halal Rating :
Last Price
$3.73
Last updated:
Market Cap
-
7D Change
1.63%
1 Year Change
28.18%
Company Overview
Exchange
Next Earnings Date
Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing cell therapies to treat cardiovascular and other diseases. The company's primary focus is on developing innovative treatments using cell technologies, particularly in cardiovascular medicine.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Caladrius Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.